Calibrate
Calibrate aims to transform obesity care by integrating clinical research, personalized coaching, and lifestyle intervention through their innovative program. They are focused on improving metabolic health outcomes for a large population with a new value-based care model. The company supports remote work and values diversity, aiming to make lasting impacts in healthcare.
Headquarters
New York, New York, United States
Company Size
201-500 employees
Founded
2020
Calibrate is a telehealth company that offers a clinically driven 'metabolic reset' designed to treat the root biological drivers of weight gain. Their program pairs physician-prescribed GLP-1 medications with 1:1 video coaching and science-backed lifestyle lessons, delivered through a tech platform to individuals and employers. Calibrate reports average member weight loss of 20% of body weight achieved over three years, emphasizing long-term metabolic health and sustained behavior change rather than short-term dieting.
Exclusive: Weight loss startup Calibrate swaps CEOs in latest leadership shakeup
May 20, 2025
Vibranium Labs Raises $4.6 Million in Seed Round
Sep 19, 2025
Metabolic health startup Calibrate names new CEO as it eyes expansion in employer, payer market
Feb 8, 2024
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Calibrate.
Weight-loss startup Calibrate cuts 18% of workforce as obesity drugs spark growing competition
Apr 14, 2023